Risk factors for very preterm delivery and delivery of very-small-for-gestational-age infants among HIV-exposed and HIV-unexposed infants in Botswana |
| |
Authors: | Natasha Parekh Sajini Souda Mompati Mmalane Max Essex Joseph Makhema |
| |
Affiliation: | a University of Miami Miller School of Medicine, Miami, USAb Harvard School of Public Health, Department of Biostatistics, Boston, USAc Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswanad Brigham and Women's Hospital, Boston, USAe Harvard School of Public Health, Department of Immunology and Infectious Diseases, Boston, USAf Massachusetts General Hospital, Boston, USAg Beth Israel Deaconess Medical Center, Division of Infectious Diseases, Boston, USA |
| |
Abstract: |
ObjectiveTo evaluate risk factors for very preterm delivery (VPTD) and very-small-for-gestational-age (VSGA) births in a country with a high HIV prevalence.MethodsObstetric records at 6 hospitals across Botswana were reviewed at delivery; VPTD was defined as birth before 32 weeks of pregnancy and VSGA as birth weight below the 3rd percentile for Botswana-specific norms.ResultsOf 16 219 live births born after 26 weeks of pregnancy, 701 (4.3%) were delivered very preterm and 607 (3.7%) were VSGA; 4347 (28.4%) were documented as HIV-exposed. In a multivariable analysis, HIV infection and hypertension during pregnancy were associated with a VPTD (adjusted odds ratio [AOR]: HIV 1.65, hypertension 1.75) and a VSGA birth (AOR: HIV infection 1.90, hypertension 3.44). Among HIV-infected women, the continuation of highly active antiretroviral therapy (HAART) from before conception was associated with a VSGA birth (AOR 1.75) but not with a VPTD (AOR 0.78). In a secondary analysis, HAART continuation was associated with hypertension during pregnancy (AOR 1.34).ConclusionHypertension and HIV infection were risk factors for a VPTD and a VSGA birth. Continuation of HAART from before conception was associated with a VSGA birth but not with a VPTD. |
| |
Keywords: | Botswana Highly active antiretroviral therapy Mother-to-child HIV transmission Very preterm delivery Very small for gestational age |
本文献已被 ScienceDirect 等数据库收录! |
|